Hikma Pharmaceuticals PLC Stock Other OTC
Stocks
HKMPF
GB00B0LCW083
Pharmaceuticals
OTC Markets Traded| Market Cap | 4.67B 4.04B 3.79B 3.45B 6.49B 447B 6.59B 44.45B 17.38B 224B 17.55B 17.17B 744B | P/E 2026 * |
12.1x | P/E 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.14B 5.31B 4.99B 4.53B 8.52B 587B 8.67B 58.42B 22.84B 294B 23.06B 22.56B 977B | EV / Sales 2026 * |
1.77x | EV / Sales 2027 * | 1.65x |
| Free-Float |
63.3% | Yield 2026 * |
3.92% | Yield 2027 * | 4.12% |
Last Transcript: Hikma Pharmaceuticals PLC
| 1 day | -1.13% |
| Manager | Title | Age | Since |
|---|---|---|---|
Said Darwazah
CEO | Chief Executive Officer | 69 | 2025-11-30 |
Areb Kurdi
DFI | Director of Finance/CFO | - | 2026-02-25 |
| Chief Tech/Sci/R&D Officer | 64 | 2026-02-25 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 69 | 2005-10-13 | |
Khalid Nabilsi
BRD | Director/Board Member | 54 | 2025-12-14 |
Said Darwazah
CHM | Chairman | 69 | 2014-05-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -.--% | - | - | 4.67B | |
| -2.25% | -0.47% | +72.43% | +119.36% | 1,078B | |
| -0.66% | +0.43% | +49.01% | +50.11% | 632B | |
| -0.54% | +1.39% | +21.88% | +63.83% | 443B | |
| -1.99% | -3.32% | +41.98% | +34.08% | 356B | |
| -1.05% | -2.81% | +24.22% | +34.67% | 289B | |
| -2.12% | -3.67% | -1.09% | +3.11% | 245B | |
| -0.63% | +1.04% | +43.03% | +59.10% | 226B | |
| -1.19% | -3.41% | -9.18% | -52.41% | 204B | |
| +0.16% | +3.87% | +16.25% | +73.27% | 171B | |
| Average | -0.71% | +0.43% | +28.73% | +42.79% | 404.85B | |
| Weighted average by Cap. | -0.08% | +0.31% | +41.45% | +62.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.46B 2.99B 2.81B 2.56B 4.81B 331B 4.89B 32.94B 12.88B 166B 13B 12.72B 551B | 3.61B 3.12B 2.93B 2.67B 5.01B 346B 5.1B 34.37B 13.44B 173B 13.57B 13.27B 575B |
| Net income | 419M 362M 340M 309M 582M 40.07B 591M 3.98B 1.56B 20.07B 1.57B 1.54B 66.68B | 456M 394M 370M 337M 633M 43.61B 643M 4.34B 1.7B 21.84B 1.71B 1.68B 72.58B |
| Net Debt | 1.47B 1.27B 1.19B 1.08B 2.04B 140B 2.07B 13.97B 5.46B 70.33B 5.51B 5.39B 234B | 1.29B 1.12B 1.05B 955M 1.79B 124B 1.82B 12.3B 4.81B 61.94B 4.86B 4.75B 206B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
